Kinetics of changes in the crypts of the jejunal mucosa of dimethylhydrazine-treated rats.
When symmetrical 1,2 dimethylhydrazine was administered to rats by weekly s.c. injection, 37% of the animals had developed small intestinal carcinomas after 21-27 weeks. These lesions were largely localized to duodenum and upper jejunum. At the same time there was a diffuse crypt hyperplasia in the jejunum which affected all the treated animals, not just those with neoplasms. This marked hyperplasia was preceded by a modest sustained crypt elongation which was seen soon after DMH injections began. In these hyperplastic jejunal crypts the absolute size of the proliferative compartment was increased, but the growth fraction calculated from labelling studies appeared to fall, probably by reduction in relative size of the proliferating population within the proliferative compartment. No convincing alteration in actual cell-cycle time was observed in the abnormal crypts. There was a slight (25%) increase in cell-production rate in the abnormal crypts.
D000818:Animals; D004127:Dimethylhydrazines; D005260:Female; D006965:Hyperplasia / Q000139:chemically induced; D007413:Intestinal Mucosa / Q000473:pathology*; D007414:Intestinal Neoplasms / Q000139:chemically induced / Q000473:pathology*; D007583:Jejunum / Q000473:pathology*; D008938:Mitosis / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology; D051381:Rats; D014750:Vincristine / Q000494:pharmacology
D004127:Dimethylhydrazines; D014750:Vincristine